Pathophysiological study on xerosis, disorders of vascular/blood flow and neuropathy in diabetic patients

oto Hiroshi0 个研究点目标入组 30 人开始时间: 2022年5月31日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Group with diabetes mellitus
•1. Male outpatients with Type 2 diabetes mellitus
•2. Patients who can give voluntary written consent to participate in the present study.
•2) Control group (Group without diabetes mellitus)
•1. adult male
•2. Persons who can give voluntary written consent to participate in the present study.

•1) Group with diabetes mellitus
•1. Patients who have/had diseases which may cause peripheral neuropathy.
•2. Patients who have /had diseases which may cause xerosis excluding due to physiological and environmental factors.
•3. Patients with skin diseases excluding xerosis at the measurement sites
•4. Patients with diabetic foot gangrene or foot ulcer.
•5. Patients who are taking drugs for neuropathic pain.
•6. Patients with mental disease
•7. Patients who are being treated with peripheral vasodilation drugs.
•8. Patients who routinely use emollient/moisturizer at the measurement sites.
•9. Patients who are considered to be unsuitable for the study by the investigator.
•2) Control group (Group without diabetes mellitus)
•1. Persons who have/had diseases which may cause peripheral neuropathy.
•2. Persons who have /had diseases which may cause xerosis.
•3. Persons with skin diseases excluding xerosis at the measurement sites
•4. Persons who are taking drugs for more than 28 days.
•5. Persons who routinely use emollient/moisturizer at the measurement sites.
•6. Persons who are considered to be unsuitable for the study by the investigator.

发起方

oto Hiroshi